References
1. Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology 2020; 158(5): 1232-1249.e3.
2. Heitmann PT, Vollebregt PF, Knowles CH, et al. Understanding the physiology of human defaecation and disorders of continence and evacuation. Nature Reviews Gastroenterology and Hepatology. Nature Research 2021;18(11):751–69.
3. Brandler J, Camilleri M. Pretest and Post-test Probabilities of Diagnoses of Rectal Evacuation Disorders Based on Symptoms, Rectal Exam, and Basic Tests: a Systematic Review. Clinical Gastroenterology and Hepatology 2020;18(11):2479–90.
4. Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430-1442.e4.
5. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.e5.
6. Serra J, Pohl D, Azpiroz F, et al. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterology and Motility 2020;32(2).
7. Mearín F, Ciriza C, Mínguez M, et al. Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig 2016;108(6):332-63.
8. Bove A, Pucciani F, Bellini M, et al. Consensus statement AIGO/SICCR: Diagnosis and treatment of chronic constipation and obstructed defecation (part I: Diagnosis). World J Gastroenterol 2012;18(14):1555-64.
9. Mearin F, Ciriza C, Mínguez M, et al. Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2). Aten Primaria 2017;49(1):42–55.
10. Nurko S, Scott SM. Coexistence of constipation and incontinence in children and adults. Best Pract Res Clin Gastroenterol 2011;25(1):29–41.
11. Deb B, Prichard DO, Bharucha AE. Constipation and Fecal Incontinence in the Elderly. Current Gastroenterology Reports 2020;22(11):54.
12. Serra J, Mascort-Roca J, Marzo-Castillejo M, et al. Guía de práctica clínica sobre el manejo del estreñimiento crónico en el paciente adulto. Parte 2: Diagnóstico y tratamiento. Gastroenterologia y Hepatologia 2017;40(4): 303–316.
13. Tantiphlachiva K, Rao P, Attaluri A, et al. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clinical Gastroenterology and Hepatology 2010;8(11):955–60.
14. Caetano AC, Santa-Cruz A, Rolanda C. Digital Rectal Examination and Balloon Expulsion Test in the Study of Defecatory Disorders: Are They Suitable as Screening or Excluding Tests? Canadian Journal of Gastroenterology and Hepatology 2016;2016:8654314.
15. Dainese R, Serra J, Azpiroz F, et al. Effects of physical activity on intestinal gas transit and evacuation in healthy subjects. American Journal of Medicine 2004;116(8):536–9.
16. Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998;45(21):727–32.
17. Lever E, Cole J, Scott SM, et al. Systematic review: The effect of prunes on gastrointestinal function. Alimentary Pharmacology and Therapeutics 2014;40(7):750–8.
18. Bijkerk CJ, Muris JWM, Knottnerus JA, et al. Systematic review: The role of different types of fibre in the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2004;19(3): 245–51.
19. Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database of Systematic Reviews 2010; (7).
20. Dipalma JA, Deridder PH, Orlando RC, et al. A Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of a New Polyethylene Glycol Laxative. Am J Gastroenterol. 2000 Feb;95(2):446-50.
21. Bharucha AE, Pemberton JH, Locke GR. American gastroenterological association technical review on constipation. Gastroenterology 2013;144(1):218–38.
22. Skardoon GR, Khera AJ, Emmanuel A V., Burgell RE. Review article: dyssynergic defaecation and biofeedback therapy in the pathophysiology and management of functional constipation. Aliment Pharmacol Ther. 2017;46(4):410-423.
23. Del Popolo G, Mosiello G, Pilati C, et al. Treatment of neurogenic bowel dysfunction using transanal irrigation: A multicenter Italian study. Spinal Cord 2008;46(7):517–22.
24. Podzemny V, Pescatori LC, Pescatori M. Management of obstructed defecation. World Journal of Gastroenterology 2015;21(4):1053–60.
25. Smith LE, Pfeifer J, Agachan F, Wexner SD. CURRENT STATUS Surgery for Constipation A Review. Dis Colon Rectum 1996;39(4):444-60.
26. Raahave D, Loud FB, Christensen E, et al. Scand J Gastroenterol 2010;45(5):592–602.
27. Drossman DA, Hasler WL. Rome IV - Functional GI disorders: Disorders of gut-brain interaction. Gastroenterology 2016;150(6):1257–61.
28. Liang J, Almario C V., Chey WD, et al.Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States. Am J Gastroenterol 2023;118(11):2033–40.
29. De Giorgio R, Zucco FM, Chiarioni G, et al. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Advances in Therapy 2021;38(7): 3589–621.
30. Farmer AD, Drewes AM, Chiarioni G, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterology Journal 2019;7(1):7–20.
31. Keefer L, Drossman DA, Guthrie E, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology 2016;150(6):1408–19.
32. Crockett SD, Greer KB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology 2019;156(1):218–26.
33. Horrigan J, Bhumi S, Miller D, et al. Management of Opioid-induced Constipation in Older Adults. J Clin Gastroenterol 2023;57(1):39–47.
34. Viscusi ER. Clinical overview and considerations for the management of opioid-induced constipation in patients with chronic noncancer pain. Clinical Journal of Pain 2019;35(2):174–88.
35. Fordtran JS, Hofmann AF. Seventy Years of Polyethylene Glycols in Gastroenterology: The Journey of PEG 4000 and 3350 From Nonabsorbable Marker to Colonoscopy Preparation to Osmotic Laxative. Gastroenterology 2017 ;152(4):675-680.
36. Freedman MD, Schwartz HJ, Roby R, Fleisher S. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. J Clin Pharmacol 1997;37(10):904–7.
37. Gudin J, Vu L, Ceschim MR, et al. Peripherally acting mu-opioid receptor antagonists for the treatment of opioid-induced constipation. Aliment Pharmacol Ther 2022;55 Suppl 2:S8–15.
38. Oriol AL, Cruz-Sequeiros C, Luque-Blanco A, Porta-Sales J. Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: Review. Revista de la Sociedad Española del Dolor 2020;27(1):37–49.
39. Informe de Posicionamiento Terapéutico de naldemedina (Rizmoic® ) en estreñimiento inducido por opioides: Ministerio de Sanidad, Consumo y Bienestar Social. Agencia Española de Medicamentos y Productos Sanitarios;2021.[https://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/2021/IPT_16--Rizmoic.pdf?x43061.
40. Katakami N, Harada T, Murata T, et. Randomized phase III and extension studies: Efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Annals of Oncology 2018;29(6):1461–7.
41. Katakami N, Harada T, Murata T, et al. Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer. J Clin Oncol [2017;35:3859–66.
42. Saito Y, Yokota T, Arai M, Tada Y, Sumitani M. Naldemedine in japanese patients with opioid-induced constipation and chronic noncancer pain: Open-label phase III studies. J Pain Res 2019;12:127–38.